Cardiol Therapeutics Inc. (CRDL.TO)

CAD 1.58

(3.95%)

Inventory Summary of Cardiol Therapeutics Inc.

  • Cardiol Therapeutics Inc.'s latest annual inventory in 2023 was -279.87 Thousand CAD , down 0.0% from previous year.
  • Cardiol Therapeutics Inc.'s latest quarterly inventory in 2024 Q2 was - CAD , down 0.0% from previous quarter.
  • Cardiol Therapeutics Inc. reported annual inventory of - CAD in 2022, down 0.0% from previous year.
  • Cardiol Therapeutics Inc. reported annual inventory of - CAD in 2021, down -100.0% from previous year.
  • Cardiol Therapeutics Inc. reported quarterly inventory of - CAD for 2024 Q1, down 0.0% from previous quarter.
  • Cardiol Therapeutics Inc. reported quarterly inventory of - CAD for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of Cardiol Therapeutics Inc. (2023 - 2017)

Historical Annual Inventory of Cardiol Therapeutics Inc. (2023 - 2017)

Year Inventory Inventory Growth
2023 -279.87 Thousand CAD 0.0%
2022 - CAD 0.0%
2021 - CAD -100.0%
2020 17.96 Thousand CAD -98.39%
2019 1.11 Million CAD -82.37%
2018 6.34 Million CAD 0.0%
2017 - CAD 0.0%

Peer Inventory Comparison of Cardiol Therapeutics Inc.

Name Inventory Inventory Difference
Aurora Cannabis Inc. 186.37 Million CAD 100.15%
Avicanna Inc. 4.54 Million CAD 106.159%
Avant Brands Inc. 28.93 Million CAD 100.967%
Crescita Therapeutics Inc. 6.12 Million CAD 104.569%
Knight Therapeutics Inc. 91.83 Million CAD 100.305%
MediPharm Labs Corp. 9.89 Million CAD 102.827%
OrganiGram Holdings Inc. 80.95 Million CAD 100.346%
Canopy Growth Corporation 77.29 Million CAD 100.362%
Willow Biosciences Inc. 221 Thousand CAD 226.639%
Auxly Cannabis Group Inc. 31.42 Million CAD 100.89%